Clinical Read2026-06-11

Delpacibart braxlosiran (del-brax) - (FORTITUDE)

Novartis AGNVS
Indication
Facioscapulohumeral muscular dystrophy (FSHD)
Stage
phase1
Event
Phase 1/2